Verified Clinical Trials (VCT) will be exhibiting again at the EUFEMED meeting in France May 15-17. VCT is the global research subject database registry utilized by phase 1- phase 4 clinical trials across the globe. VCT prevents over enrollment or duplicate subjects as well as many other key protocol violations to promote safety and data …
Professional research subjects or duplicate subjects in clinical trials cause safety concerns and poor quality data. The Verified Clinical Trials global research subject database registry is a tool to detect duplicate subjects and prevents many protocol violations proactively at the time of screening. What we have learned from experience and analytical data review over the …
Duplicate subjects exist in most clinical trials to varying degrees. CNS clinical trials are especially prone to duplicate subject or over enrollment. The issue exists from phase 1 healthy volunteer studies to multiple phase 2/3 clinical trials across many therapeutic indications. Use of global research subject database registry such as Verified Clinical Trials will help …
Mature data collected from North America as well as in Europe demonstrates how research volunteers will travel large distances to screen or enroll contemporaneously in multiple clinical trials as duplicate subjects in clinical trials. The numbers are significant and occur across both early and later phase studies. Why risk these safety and data quality issues? …
Verified Clinical Trials (VCT) has been well adopted in many research sites and CROs in several European countries. Data again proves that research volunteers will travel significant distances to dual enroll in multiple clinical trials contemporaneously. There is a similar experience in the United States whereby duplicate subjects in clinical trials will travel thousands of …
Duplicate subjects in clinical trials is unfortunately a common issue that affects all trials from most every indication and across all phases of clinical trials research. These professional research subjects can be prevented by using Verified Clinical Trials (VCT) the global research subject registry. Nearly all of the phase 1 units across the United States …
Having a system, or research subject database registry, to proactively detect and prevent duplicate subjects and other protocol violations has become a well recognized and important step to protect the data quality and improve research subject safety. This is NOT limited to phase 1 healthy volunteer studies. This happens with significant frequency across multiple therapeutic …
Join us at #ASCP2019 in Phoenix this year Wed. May 29th at 1 PM as VCT hosts an expert panel on professional research subjects and duplicate subjects in CNS clinical trials. Duplicate subjects can ruin a trial, especially in the CNS space. Without a research subject database registry like Verified Clinical Trials it is nearly impossible …
Garden City, NY. March 5th2019–Verified Clinical Trials has been named a finalist in “Best Sponsor-Focused Technological Development” in the CARE Awards, which recognize outstanding work across the global clinical research enterprise. The 2019 winners will be announced at a ceremony on Thursday, 2 May at the Hyatt Regency Boston, MA, where we gather distinguished leaders …
Preventable protocol violations and professional research subjects exist across the globe. It is NOT just a regional problem. If you look at the protocol violations by verification with the Verified Clinical Trials (VCT) system one can see that the issue is significant throughout the country. Duplicate subjects can cause a trial to fail. Issues with increased …
